Nevro Lands $58,000,000 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=43f43f65-2991-46db-90d1-dde3ffc96c6d&Preview=1 - Date
7/20/2011 - Company Name
Nevro - Mailing Address
4040 Campbell Avenue Menlo Park, CA 94025 - Company Description
Nevro is a medical device company developing novel neuromodulation therapies for multiple indications. The company’s initial focus is the development of an implantable device for the treatment of chronic pain. - Website
http://www.nevrocorp.com - Transaction Type
Venture Equity - Transaction Amount
$58,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
The funds will be used to sponsor a pivotal clinical study in the U.S. and provide continued support for the company’s international commercialization strategy. - M&A Terms
- Venture Investor
Johnson & Johnson Development Corporation - Venture Investor
Aberdare Ventures - Venture Investor
Three Arch Partners - Venture Investor
Bay City Capital - Venture Investor
Accuitive Medical Ventures - Venture Investor
Mayo Medical Ventures - Venture Investor
MPM Capital
